Replies to post #115 on Aralez Pharmaceuticals Inc. (fka ARLZQ)

[$Pistol Pete$]

$ARLZ Guggenheim Reiterates Buy on Aralez Pharma (ARLZ) Following Yosprala Approval

Guggenheim reiterated a Buy rating and $12.00 price target on Aralez Pharmaceuticals (NASDAQ: ARLZ) following the approval of Yosprala and the recent acquisition of Zontivity

http://www.streetinsider.com/Analyst+Comments/Guggenheim+Reiterates+Buy+on+Aralez+Pharma+(ARLZ)+Following+Yosprala+Approval/12037074.html




Go $ARLZ